Tecfidera (dimethyl fumarate) Information
Tecfidera is approved to treat people with relapsing Multiple Sclerosis (MS).
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
Tecfidera is approved to treat people with relapsing Multiple Sclerosis (MS).